Nystagmus is a vision associated medical condition, characterized by repetitive and uncontrolled movements of the eye. These movements often result in reduced vision and can further affect the balance and coordination of the body. Fatigue and stress worsen the prognosis of nystagmus. However, the exact cause for the condition is still unknown. The major causes of nystagmus identified include congenital neurological problem or neurological disorders developed in early childhood. Other causes of nystagmus include lack of development of normal eye movement in early life, refractive error, for example, near-sightedness (myopia) or astigmatism, inflammation of the inner ear, medications such as anti-epilepsy drugs, and central nervous system diseases among others

The Nystagmus Market growth is majorly attributed to the increasing prevalence of the genetic and eye related disorders. Moreover, increasing mental retardation and neurological abnormalities will drive the market growth.

According to the World Health Organization (WHO), an estimated 253 million people live with vision impairment, 36 million are blind, and 217 million have moderate to severe vision impairment worldwide. An estimated 19 million children (below age 15) are vision impaired.

According to the WHO estimates, neurological abnormalities are responsible for 4.5%-11% of all illnesses in the low or high-income economies. This is far higher as compared to the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.

However, availability of expensive treatment and poor reimbursement policies in the developing regions of the world are some of the factors, which may hamper the market growth during the forecast period.

Key Players:

Global Nystagmus Market Top Vendors are Bristol-Myers Squibb Company, NUSAPURE, ALLERGAN, Aerie Pharmaceuticals, Inc., Pfizer Inc., Valeant Pharmaceuticals International, Inc., Bayer AG, Genentech, Inc., Novartis AG, Regeneron Pharmaceuticals, Inc., Shire, and Santen Pharmaceutical Co., Ltd., and others.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5441 .

Segmentation:

The nystagmus is segmented on the basis of type, diagnosis, treatment, and end-users.

Based on the type, the market is segmented into infantile, latent nystagmus, noonan syndrome, and nystagmus blockage syndrome.

On the basis of the diagnosis, the market is segmented into CT scan, MR scan, chromosome analysis, ultrasonography, and others.

On the basis of the treatment, the market is segmented into medications, surgical, and others.

On the basis of the end-user, the market is segmented into hospitals & clinics, research centers, specialty eye clinics, and others.

Regional Analysis:

The Global Nystagmus Market consists of countries namely the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas dominate the Global Nystagmus Market owing to well-developed technology, increasing number of patients with eye-related problems, high healthcare spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies in the region have fuelled the growth of the market in this region.

Europe holds the second position in the Global Nystagmus Market owing to the government support for research & development and availability of funds for research. Moreover, this is expected to continue to drive the European market over the forecasted period. For instance, countries like Germany and France are increasing their investments in the healthcare domain.

Asia Pacific is the fastest growing Nystagmus Market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods for eye diseases in countries like India and South Korea is likely to emerge as the fastest growing market across the globe. Furthermore, growing demand for quality devices in the healthcare sector is projected to lead the use of advanced equipment, which, in turn, will increase the market growth of nystagmus in the region.

On the other hand, in the Middle East and Africa, eye problems have become a huge issue due to limited screening, ignorance of diseases, and poor access to treatment.

Apply for Discount @ https://www.marketresearchfuture.com/check-discount/5441 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]